Medication for all
at the heart of our concerns.
Our mission
We are committed to serving both patients and healthcare professionals.
Ethyx Pharmaceuticals is an independent French pharmaceutical laboratory which provides healthcare professionals with recognized therapies, supported by fully committed partners and a dedicated team.
We approach all health issues with respect and empathy.
Would you like to
discover our products?
Our firm objective is to enable as many people as possible to access quality products. All our efforts are focused on achieving this goal.
Ethyx Pharmaceuticals is committed to offering medicines which cover a wide range of therapeutic areas:
Cardiology
Dermatology
Metabolism
Rheumatology
Pneumology
Neurologie
Our business
The strategy of our company is based on the acquisition of mature originator drugs. Benefiting from an efficient and global operational platform, our laboratory teams integrate the drugs into the portfolio, ensuring that optimum quality is maintained and that they are constantly available to patients and healthcare professionals. Through in-depth medical monitoring, we breathe new life into the drugs in our portfolio, and our regulatory expertise enables them to be registered and launched in previously unexplored territories.
We are constantly on the look-out for new acquisition opportunities to be able to increase our current offer of fully medically valuable drugs.
Our business
The strategy of our company is based on the acquisition of mature originator drugs. Benefiting from an efficient and global operational platform, our laboratory teams integrate the drugs into the portfolio, ensuring that optimum quality is maintained and that they are constantly available to patients and healthcare professionals. Through in-depth medical monitoring, we breathe new life into the drugs in our portfolio, and our regulatory expertise enables them to be registered and launched in previously unexplored territories.
We are constantly on the look-out for new acquisition opportunities to be able to increase our current offer of fully medically valuable drugs.